Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Case Study, News


Huntington’s disease: service model co-production

Huntington’s disease: service model co-production
Case StudyNews Ageing well Surrey Health and care professionalsLife sciences and industryPatients and public

There is currently no NHS service model for the care of people with Huntington’s disease (HD), meaning care standards vary nationwide. HD progressively affects a person’s everyday functions and, while medications and interventions can help control its effects, there is no way to prevent its progression and it is ultimately fatal. Numerous clinical professionals are required to support those affected, creating a complex pathway of care.

Co-production of service model

A collaborative project involving Surrey Heartlands, KSS AHSN, Roche Products Ltd. and the Huntington’s Disease Association (HDA), from July 2021 to January 2022, aimed to build on existing services to develop a fit-for-purpose service model providing equitable care. It took a co-production/co-design approach, with stakeholders from project partners, St George’s Hospital, local health and social care professionals, patients, families and carers.

Engagement included surveying patients, families and carers across England to understand where current care services worked well, and two Surrey specific co-design events. Learning from this helped shape a service delivery model for HD patients in Surrey, and led to the successful proposal to develop and recruit to a new HD coordinator post.

KSS AHSN was approached by Surrey Heartlands to provide additional project management expertise and capacity, including overseeing creation of the final report, and the outputs are being shared with NHS commissioners in London and Leicestershire.

Read the report

Related news

The Women’s Health Research Network was set up by Health Innovation KSS and University Hospitals Sussex NHS Foundation Trust in May 2023 in response to the National Women’s Health Strategy for England.

Case StudyNews

8 Jan 2025

More

People living with dementia often struggle to access health and care services, with important changes in their wellbeing frequently going...

News

18 Dec 2024

More

Dementia is one of the UK’s most significant health challenges. Currently, around 900,000 people are living with dementia in the UK, and...

News

9 Dec 2024

More